 |
|
NADPH oxidase inhibitor development for diabetic nephropathy through water tank model
Hye Eun Lee, Seunghwan Shim, Yongseok Choi, Yun Soo Bae
Kidney Res Clin Pract. 2022;41(Suppl 2):S89-S98. Published online 2022 Jul 19 DOI: https://doi.org/10.23876/j.krcp.21.269
|
|
Citations to this article as recorded by
 Simulation and Evaluation of Runoff in Tributary of Weihe River Basin in Western China
Yinge Liu, Yang Su, Lingang Wang, Yaqian Zhao
Water.2024; 16(2): 221. CrossRef Inositols in treating polycystic ovary syndrome and non-insulin dependent diabetes mellitus: now and the future
Antonio Simone Laganà , Samuel H. Myers, Gianpiero Forte, Antoine Naem, Harald Krentel, Leila Allahqoli, Ibrahim Alkatout, Vittorio Unfer
Expert Opinion on Drug Metabolism & Toxicology.2024; 20(1-2): 61. CrossRef Nox4-SH3YL1 complex is involved in diabetic nephropathy
Sae Rom Lee, Hye Eun Lee, Jung-Yeon Yoo, Eun Jung An, Soo-Jin Song, Ki-Hwan Han, Dae Ryong Cha, Yun Soo Bae
iScience.2024; 27(2): 108868. CrossRef Antibiotic-induced intestinal microbiota depletion can attenuate the acute kidney injury to chronic kidney disease transition via NADPH oxidase 2 and trimethylamine-N-oxide inhibition
Jeonghwan Lee, Jinhaeng Lee, Kyuhong Kim, Jiwon Lee, Youngae Jung, Jin Seong Hyeon, Areum Seo, Wencheng Jin, Boram Weon, Nayeon Shin, Sejoong Kim, Chun Soo Lim, Yon Su Kim, Jung Pyo Lee, Geum-Sook Hwang, Seung Hee Yang
Kidney International.2024; 105(6): 1239. CrossRef Bioenergetics: the evolutionary basis of progressive kidney disease
Robert L. Chevalier
Physiological Reviews.2023; 103(4): 2451. CrossRef Diabetic kidney disease, revisited: where do we stand?
Dae Ryong Cha
Kidney Research and Clinical Practice.2022; 41(Suppl 2): S31. CrossRef
|